PUBLISHED DATE : Dec 2021 | Pages : 377
Fill out your details & get your free sample
Healthcare Artificial Intelligence Market Size, Share, & Trends Analysis Report by Category (Software & Services and Hardware), Application (Hospital Workflow Management, Medical Imagine and Diagnosis, Drug Discovery and Precision Medicine, and Patient Management), Technology (Machine Learning, Querying Method, Natural Language Processing, and Others), End-users (Healthcare Providers, Pharma-biotech and medical device companies, Payers, and Others) and Geography (North America, Europe, APAC, Latin America, and Middle East & Africa); Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021–2026.
377 Pages
188 Tables
167 Charts
5 Regions
20 Countries
37 Companies
5 Market Segment
| Report Attribute | Details |
|---|---|
| MARKET SIZE (REVENUE) | USD 44.5 BILLION (2026) |
| CAGR | 46.21% (2021-2026) |
| BASE YEAR | 2020 |
| FORECAST YEAR | 2021-2026 |
| MARKET SEGMENTS | Category (Software & Services and Hardware), Application (Hospital Workflow Management, Medical Imaging and Diagnosis, Drug Discovery and Precision Medicine, and Patient Management), Technology (Machine Learning, Querying Method, Natural Language Processing, and Others), and End-Users (Healthcare Providers, Pharma-biotech and medical device companies, Payers, and Others) |
| GEOGRAHIC ANALYSIS | North America, Europe, APAC, Latin America, Middle East & Africa |
| COUNTRIES COVERED | US, Canada, Germany, UK, France, Italy, Spain, Nordic Countries, China, India, Japan, Australia, South Korea, Rest of APAC, Brazil, Mexico, Argentina, Turkey, Saudi Arabia, South Africa, and UAE |
The global healthcare artificial intelligence (AI) market was valued at USD 4.56 Billion in 2020 and is expected to reach USD 44.5 billion by 2026, growing at a CAGR of 46.21% during the forecast period.
Several pharmaceutical companies are implementing innovative technologies to boost their growth in the global healthcare industry. Collaboration of GSK with Exscientia identified a small compound for targeted therapeutics and its characteristics towards the specific target using the AI platform. AI is becoming an incredible platform in the pharmaceutical industry. For instance, Novartis announced Microsoft as a strategic partner in AI and data science to set up an AI innovation lab. Since the last year, over 50+ companies have got machine learning and AI algorithms approvals. During the COVID-19 pandemic, AI played a significant role in the healthcare industry. An analytics study by Accenture combined with clinical applications demonstrated the potential of AI to reduce approximately USD 150 billion per annum by 2026 in the US healthcare system.
This research report includes a detailed segmentation by
The software industry provides numerous services to the healthcare industry. With the advent of medical software, human errors are minimized in the global medical market. Using advanced software in healthcare enables the clinical experts to expertise their practices. Software providers are gaining huge opportunities in the healthcare artificial intelligence (AI) market. Software development companies are constantly striving to improve the industry and bring innovations. In 2020, the global healthcare artificial intelligence (AI) market by software & services was valued at USD 3371.68 million. The development of AI solutions helps doctors to optimize workflows by extracting insights from the data.
Machine learning is the subset of AI and gaining high traction in artificial intelligence (AI) across the healthcare industry. The future development of machine learning in the medical field will continue to transform the medical industry into a newer version. Companies are demanding high for machine learning engineers to develop algorithms that will boost business growth and efficiency. Investments in AI and machine learning largely benefit the healthcare industry, and the investments are expected to increase in the future.
US is the major revenue generator of the healthcare artificial intelligence (AI) market across the North American region. In North America, the potential increase in AI GDP is compounded by tremendous opportunities to adopt more productive technologies. In 2020, Canada accounted for a share of 6.72% of the North American healthcare artificial intelligence (AI) market. The advent of AI holds the potential to restore balance, and Canada is uniquely positioned as a world leader in systems design using AI technology. Canada’s AI talent pipelines continue to be an important focus on AI advisory boards. The Commission will expand Canada’s talent base in technology & business and raise awareness of AI as a pioneer in AI employment in the upcoming years.
Giant players are focusing on pursuing organic growth strategies to enhance their product portfolio in the healthcare artificial intelligence (AI) market. Several initiatives by the players will complement growth strategies, which are gaining traction among end-users in the market. Rising growth of startups collaborating with key vendors in promoting their artificial intelligence in healthcare applications creating heavy competition in the market. For instance, Google is one of the major players offering artificial intelligence in the healthcare sector; by creating advanced AI research and mobile tools, the company is positively impacting patients and hospitals. Deep Mind, an advanced AI company, teamed up with Google to develop better solutions in healthcare. Players are facing heavy competition with other players in the healthcare artificial intelligence (AI) market.
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
Fill out your details & get your free sample
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
Want to know more about the report or any specific requirement?
Click to Email +1-312-235-2040
